KBD4466, a Selective TLR 7/8 Inhibitor, for the Treatment of Autoimmune Diseases. KBD4466 demonstrates excellent cellular activity, favorable pharmacokinetic properties, potent inhibition of cytokine production in mouse pharmacodynamic studies, and outstanding therapeutic efficacy in an SLE animal model.
MedKoo Cat#: 129094
Name: KBD4466
CAS#: N/A
Chemical Formula: C24H23F3N6O
Exact Mass: 468.1885
Molecular Weight: 468.48
Elemental Analysis: C, 61.53; H, 4.95; F, 12.17; N, 17.94; O, 3.42
The following data is based on the product molecular weight 468.48 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
Yuan Y, Wei Y, Jia Z, Chu H, Kong D, Lei F, Ye F, Qian X, Zhang J, Zhou X, Zhu X, Li Z, Liang X, Chen W. Discovery of KBD4466, a Selective TLR 7/8 Inhibitor, for the Treatment of Autoimmune Diseases. J Med Chem. 2025 Jul 1. doi: 10.1021/acs.jmedchem.5c00656. Epub ahead of print. PMID: 40591919.